Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 12, 2007, Pages 2288-2291

  Crozier, Joseph E M ^a   McMillan, Donald C ^a,b   McArdle, Colin S ^a   Angerson, Wilson J ^a   Anderson, John H ^a   Horgan, Paul G ^a   McKee, Ruth F ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b University Department of Surgery   (United Kingdom)

Author keywords

C reactive protein; Colorectal cancer; TNM stage; Tumor diameter

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 36349003339     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04792.x     Document Type: Article

References (12)

1. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br. J. Cancer 2002 86 : 331 5.
2. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative increase in serum C-reactive protein concentration as an indicator of prognosis in colorectal cancer. Am. J. Surg. 1998 176 : 335 8.
3. Nielsen HJ, Christensen IJ, Sorensen S, Moesgaard F, Brunner N. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann. Surg. Oncol. 2000 7 : 617 23.
4. McMillan DC, Canna K, McArdle CS. A systemic inflammatory response predicts survival following curative resection for colorectal cancer. Br. J. Surg. 2003 90 : 215 19.
5. Canna K, McMillan DC, McKee RF, McNicol AM, Horgan PG, McArdle CS. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br. J. Cancer 2004 90 : 1707 9.
6. Chung YC, Chang YF. Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J. Gastroenterol. Hepatol. 2003 15 : 369 73.
7. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edn. New York : Springer-Verlag, 2002 113 25.
8. Scottish Cancer Intelligence Unit. Trends in Cancer Survival in Scotland 1971-1995. Edinburgh : Information and Statistics Division, 2000.
9. O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr. Cancer 2000 37 : 36 40.
10. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am. J. Surg. 1995 170 : 319 22.
11. Canna K, McArdle PA, McMillan DC et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br. J. Cancer 2005 92 : 651 4.
12. Nozoe T, Matsumata T, Sugimachi K. Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am. J. Clin. Oncol. 2000 23 : 263 6.